These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32613686)

  • 61. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
    Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
    J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
    Moberg LM; Nilsson PM; Samsioe G; Borgfeldt C
    Maturitas; 2014 Aug; 78(4):310-5. PubMed ID: 24958166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients.
    Lenihan CR; Sukumaran Nair S; Vangala C; Ramanathan V; Montez-Rath ME; Winkelmayer WC
    Am J Kidney Dis; 2017 May; 69(5):595-601. PubMed ID: 27866965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study.
    Kim SY; Lee CH; Min C; Yoo DM; Choi HG
    Curr Issues Mol Biol; 2021 May; 43(1):142-152. PubMed ID: 34070082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals.
    Nguyen NTH; Huang CW; Wang CH; Lin MC; Hsu JC; Hsu MH; Iqbal U; Nguyen PA; Yang HC
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between proton pump inhibitor use and risk of fracture: A population-based case-control study.
    Kim JJ; Jang EJ; Park J; Sohn HS
    PLoS One; 2020; 15(7):e0235163. PubMed ID: 32730257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis.
    Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS;
    Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort.
    Thereaux J; Lesuffleur T; Czernichow S; Basdevant A; Msika S; Nocca D; Millat B; Fagot-Campagna A
    Surg Obes Relat Dis; 2017 Jun; 13(6):951-959. PubMed ID: 28223087
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.
    Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.
    McGowan B; Bennett K; Barry M
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):763-9. PubMed ID: 20582909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
    Hwang IC; Chang J; Park SM
    PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study.
    Cetin H; Sun J; Almqvist C; Reichardt B; Tomschik M; Zimprich F; Fang F; Ingre C
    Sci Rep; 2020 Aug; 10(1):13371. PubMed ID: 32770128
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA
    Am J Gastroenterol; 2020 May; 115(5):706-715. PubMed ID: 32205645
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
    Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
    Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.